Dr. Helen Chen Recognized as February’s Innovation Honoree

Tuesday, February 26th, 2013

February 2013 Innovation Honoree Dr. Helen Chen

On February 12, 2013 Dr. Helen Chen, CEO of Ambryx Biotechnology, was recognized as the Mayor’s Innovation Honoree for February for her work in Riverside and beyond.

City of Riverside Technology Ombudsman Greg Lee described the Yale and UC San Diego graduate as “a person who is not only involved in the development of a cure for cancer through her company, Ambryx, but who is also a mentor, leader and a friend to our high tech community.”

Ambryx Biotechnology is a privately-held pharmaceutical company founded in 1997 that specializes in the research, development and commercialization of cancer treatment drugs and clinical nutrition. Since moving her company to Riverside in 2005, Dr. Chen has been working with the city and the Riverside Technology CEO Forum to grow local tech companies; she serves as a mentor to professors who are starting their own companies and also to college students working at Ambryx as interns, as well as to younger female students interested in science, technology, engineering and math.

“Helen has been instrumental in developing our high tech sector in Riverside since her arrival and continues to be a shining star throughout the region,” stated Lee.

In her response, Dr. Chen stated that “creativity comes from concept through commercialization, and this certainly couldn’t be done just by one person, but by a team of people” and expressed her gratitude and recognition of her team at Ambryx, the local technology community, Gordon Bourns (who houses the technology incubator in which Ambryx is located), and the City of Riverside.

“When Ambryx moved to Riverside, what made a lasting impression is the City’s commitment to the technology community,” explained Chen.

Mayor Bailey summarized the recognition of Dr. Helen Chen by stating that Riverside is “grateful and blessed to have you as a part of our city”.

To watch the full Innovation Honoree presentation, click here.